TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT05351047 — Predictive Biomarker (PRD): APOL1 mRNA
Genes: APOL1; APOL
Study NCT05254626 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05254626 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT05254626 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study NCT05139472 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05147090 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT06384001 — Pharmacodynamic Biomarker (PDY): Lysosomal acid glucosylceramidase
Genes: GBA1; GBA; GC; GLUC
Study NCT05801575 — Predictive Biomarker (PRD): CHM mRNA
Genes: CHM; REP1; TCD
Study NCT06014398 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT05390528 — Predictive Biomarker (PRD): TIGIT mRNA
Genes: TIGIT; VSIG9; VSTM3
Study NCT05390528 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT05379803 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06013657 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT05546294 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT06297239 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06466746 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT06466746 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06133062 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06133062 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT06133062 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04844684 — Predictive Biomarker (PRD): HSD11B1 mRNA
Genes: HSD11B1; HSD11; HSD11L; SDR26C1
Study NCT04844684 — Predictive Biomarker (PRD): AKR1D1 mRNA
Genes: AKR1D1; SRD5B1
Study NCT06384534 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT06191458 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study NCT06071377 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study NCT06412653 — Predictive Biomarker (PRD): GNAO1 mRNA
Genes: GNAO1
Study NCT06647940 — Predictive Biomarker (PRD): CD5 mRNA
Genes: CD5; LEU1
Study NCT06598098 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06598098 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06650319 — Predictive Biomarker (PRD): ATP7B mRNA
Genes: ATP7B; PWD; WC1; WND
Study NCT06013592 — Predictive Biomarker (PRD): LEAP2 mRNA
Genes: LEAP2
Study NCT06594549 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06652724 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT04990869 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT06588127 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06604260 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT06586684 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT06499168 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06499168 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05997264 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06580613 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05091749 — Safety Biomarker (SAF): ADORA2A
Genes: RDC8
Study NCT05740085 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06149351 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT06372938 — Predictive Biomarker (PRD): FGR mRNA
Genes: FGR; SRC2
Study NCT05165355 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06547619 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT06155747 — Predictive Biomarker (PRD): NTM mRNA
Genes: NTM; IGLON2; NT; UNQ297/PRO337
Study NCT04911075 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT05795101 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05795101 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05753150 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study NCT04478201 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT06026592 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Plasma DNA
Study NCT06026592 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT05435781 — Predictive Biomarker (PRD): GCA mRNA
Genes: GCA; GCL
Study NCT05435781 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT04936945 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04791995 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06065176 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05966467 — Predictive Biomarker (PRD): AQP4 mRNA
Genes: AQP4
Study NCT05966467 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study NCT05966467 — Predictive Biomarker (PRD): Anti-aquaporin-4 antibody
Study NCT06387121 — Predictive Biomarker (PRD): CD55 mRNA
Genes: CD55; CR; DAF
Study NCT06506253 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT06537479 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT00811031 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT06027736 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT05864742 — Predictive Biomarker (PRD): SMARCA2 mRNA
Genes: SMARCA2; BAF190B; BRM; SNF2A; SNF2L2
Study NCT04698252 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05383404 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06222853 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05684055 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05484479 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT06423885 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05104333 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05104333 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05620147 — Surrogate Endpoint (SUR): Bacterial count
Study NCT05602662 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04817670 — Predictive Biomarker (PRD): VIT mRNA
Genes: VIT; UNQ647/PRO1277
Study NCT04817670 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT06287814 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04977765 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06220435 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT05571748 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study NCT06049381 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT06018558 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT06702228 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06702488 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06648018 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05476042 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06160128 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05763875 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT05763875 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05682508 — Surrogate Endpoint (SUR): Serum potassium
Study NCT04692103 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT04692103 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06221488 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT04621110 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04190056 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT05077176 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04328714 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT06329830 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04786743 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04924712 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT04909879 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT05080699 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06116136 — Predictive Biomarker (PRD): KLRC1 mRNA
Genes: KLRC1; NKG2A
Study NCT06116136 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT04872413 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT04757766 — Predictive Biomarker (PRD): C6 mRNA
Genes: C6
Study NCT06209008 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT06209008 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06476236 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04792567 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06271226 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05189067 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05919693 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06219018 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT06585241 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06585241 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05126472 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT06386965 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05948475 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study NCT04333745 — Surrogate Endpoint (SUR): Urinary oxalate
Study NCT05482048 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05629429 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT05629429 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04901481 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT05030779 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05030779 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT04587856 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT04939610 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT05847309 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06735742 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04842617 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05509478 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study NCT06145399 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT05508009 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05774795 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT05255861 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study NCT05239130 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05400070 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT05782283 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT06399900 — Predictive Biomarker (PRD): TNFSF14 mRNA
Genes: TNFSF14; HVEML; LIGHT; UNQ391/PRO726
Study NCT05008536 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT04791839 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04791839 — Predictive Biomarker (PRD): TIGIT mRNA
Genes: TIGIT; VSIG9; VSTM3
Study NCT06006169 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study NCT05553483 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT05971862 — Predictive Biomarker (PRD): SKI mRNA
Genes: SKI
Study NCT05212506 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05351827 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00001096 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00001096 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06226064 — Predictive Biomarker (PRD): GRN mRNA
Genes: GRN
Study NCT05157386 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06098131 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05334303 — Predictive Biomarker (PRD): MLH1 mRNA
Genes: MLH1; COCA2
Study NCT04957550 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study NCT06647238 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06124027 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT05737485 — Predictive Biomarker (PRD): DNAI1 mRNA
Genes: DNAI1
Study NCT05642858 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00000667 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06241807 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06241807 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT06241807 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT06566638 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT04659044 — Predictive Biomarker (PRD): CD79B mRNA
Genes: CD79B; B29; IGB
Study NCT04659044 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT04659044 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05892068 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04778982 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05346666 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05071287 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study NCT05238909 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT05643495 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study NCT05659979 — Predictive Biomarker (PRD): CGA mRNA
Genes: CGA
Study NCT05913154 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT00870636 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05464680 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05898009 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT06596967 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06590324 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06653738 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT06281067 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study NCT06565702 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06588803 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study NCT06601920 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05460221 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06585995 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT06585995 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06482723 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05451849 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study NCT06589895 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06594172 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT06596057 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04836637 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05885295 — Predictive Biomarker (PRD): DOCK3 mRNA
Genes: DOCK3; KIAA0299; MOCA
Study NCT06031532 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT06031532 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT05896488 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT05896488 — Predictive Biomarker (PRD): CFTR
Genes: MRP7; ABC35; TNR-CFTR; dJ760C5.1; CFTR/MRP
Study NCT06150651 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06513026 — Predictive Biomarker (PRD): LCT mRNA
Genes: LCT; LPH
Study NCT06345729 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT03105232 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT06023758 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06422975 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT06422975 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT04865887 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04865887 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT05690464 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05866952 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06145880 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05845671 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05845671 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT05845671 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT05845671 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02403505 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT05621070 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT05459077 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05310643 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05310643 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05310643 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05310643 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT05310643 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04897984 — Predictive Biomarker (PRD): LEAP2 mRNA
Genes: LEAP2
Study NCT05005455 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04784325 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT05902962 — Predictive Biomarker (PRD): PRPF31 mRNA
Genes: PRPF31; PRP31
Study NCT05394025 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06453707 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study NCT05889104 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06178445 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06178445 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05519527 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT05879185 — Predictive Biomarker (PRD): ICOS mRNA
Genes: ICOS; AILIM
Study NCT06525766 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06525766 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT05014360 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT06263543 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06263543 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06263543 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06263543 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05985954 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01865630 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05345418 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT04909073 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06467825 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05342662 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06242379 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT05442554 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT06088992 — Predictive Biomarker (PRD): RPE65 mRNA
Genes: RPE65
Study NCT06560489 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06560489 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05210283 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05753267 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT05054621 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06568471 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT06327945 — Predictive Biomarker (PRD): PGD mRNA
Genes: PGD; PGDH
Study NCT05892315 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT05960097 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06303284 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05614531 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study NCT05943405 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study NCT05943405 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05651854 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05001984 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT05001984 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05981703 — Predictive Biomarker (PRD): MAP4K1 mRNA
Genes: MAP4K1; HPK1
Study NCT06071767 — Predictive Biomarker (PRD): TLR7 mRNA
Genes: TLR7; UNQ248/PRO285
Study NCT04220723 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04969991 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04907916 — Predictive Biomarker (PRD): ADAM17 mRNA
Genes: ADAM17; CSVP; TACE
Study NCT06444308 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05923541 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study NCT04715880 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05098210 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05098210 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04662944 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF